Which has better valuation and earnings, WAY or HTFL?

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.47 $112.09M $0.70 36.61 Heartflow $176.03M 24.78 -$116.79M -$1.83 N/A

Is WAY or HTFL more profitable?

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Heartflow -55.82% -23.52% -18.66%

Does the media refer more to WAY or HTFL?

In the previous week, Heartflow had 13 more articles in the media than Waystar. MarketBeat recorded 18 mentions for Heartflow and 5 mentions for Waystar. Waystar's average media sentiment score of 0.46 beat Heartflow's score of 0.44 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Heartflow 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, DOCS or HTFL?

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 7.31 $196.05M $0.85 31.13 Heartflow $176.03M 24.78 -$116.79M -$1.83 N/A

Is DOCS or HTFL more profitable?

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Heartflow -55.82% -23.52% -18.66%

Does the media refer more to DOCS or HTFL?

In the previous week, Doximity had 19 more articles in the media than Heartflow. MarketBeat recorded 37 mentions for Doximity and 18 mentions for Heartflow. Heartflow's average media sentiment score of 0.44 beat Doximity's score of 0.01 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 4 Very Positive mention(s) 2 Positive mention(s) 25 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Neutral Heartflow 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, SDGR or HTFL?

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Schrodinger $255.87M 8.86 -$103.26M -$0.74 N/A Heartflow $176.03M 24.78 -$116.79M -$1.83 N/A

Is SDGR or HTFL more profitable?

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Schrodinger -20.98% -16.37% -8.19% Heartflow -55.82% -23.52% -18.66%

Does the media refer more to SDGR or HTFL?

In the previous week, Heartflow had 3 more articles in the media than Schrodinger. MarketBeat recorded 18 mentions for Heartflow and 15 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.62 beat Heartflow's score of 0.44 indicating that Schrodinger is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Schrodinger 7 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, CERT or HTFL?

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.22 -$1.60M -$0.45 N/A Heartflow $176.03M 24.78 -$116.79M -$1.83 N/A

Is CERT or HTFL more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Heartflow -55.82% -23.52% -18.66%

Does the media prefer CERT or HTFL?

In the previous week, Heartflow had 17 more articles in the media than Certara. MarketBeat recorded 18 mentions for Heartflow and 1 mentions for Certara. Heartflow's average media sentiment score of 0.44 beat Certara's score of -0.38 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Heartflow 6 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, HTFL or GDRX?

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 24.78 -$116.79M -$1.83 N/A GoodRx $796.85M 1.48 $30.44M $0.04 86.00

Is HTFL or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -55.82% -23.52% -18.66% GoodRx 2.07% 7.22% 2.53%

Heartflow (HTFL) Competitors

$50.17 -0.16 (-0.32%)

Closing price 09/22/2026 04:00 PM Eastern

Extended Trading

$50.25 +0.08 (+0.16%)

As of 04:11 AM Eastern

Compare

HTFL vs. WAY, DOCS, SDGR, CERT, and GDRX

Should you buy Heartflow stock or one of its competitors? Heartflow's main competitors and comparable companies include Waystar (WAY), Doximity (DOCS), Schrodinger (SDGR), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Heartflow compare to Waystar?

Waystar (NASDAQ:WAY) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

In the previous week, Heartflow had 13 more articles in the media than Waystar. MarketBeat recorded 18 mentions for Heartflow and 5 mentions for Waystar. Waystar's average media sentiment score of 0.46 beat Heartflow's score of 0.44 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Heartflow	6 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Heartflow	-55.82%	-23.52%	-18.66%

Waystar currently has a consensus target price of $34.67, suggesting a potential upside of 35.26%. Heartflow has a consensus target price of $46.25, suggesting a potential downside of 7.81%. Given Waystar's stronger consensus rating and higher probable upside, research analysts plainly believe Waystar is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.47	$112.09M	$0.70	36.61
Heartflow	$176.03M	24.78	-$116.79M	-$1.83	N/A

Summary

Waystar beats Heartflow on 12 of the 14 factors compared between the two stocks.

How does Heartflow compare to Doximity?

Doximity (NYSE:DOCS) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

Doximity has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	7.31	$196.05M	$0.85	31.13
Heartflow	$176.03M	24.78	-$116.79M	-$1.83	N/A

Doximity currently has a consensus price target of $32.18, indicating a potential upside of 21.63%. Heartflow has a consensus price target of $46.25, indicating a potential downside of 7.81%. Given Doximity's higher probable upside, analysts plainly believe Doximity is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Doximity had 19 more articles in the media than Heartflow. MarketBeat recorded 37 mentions for Doximity and 18 mentions for Heartflow. Heartflow's average media sentiment score of 0.44 beat Doximity's score of 0.01 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	4 Very Positive mention(s)	2 Positive mention(s)	25 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Neutral
Heartflow	6 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Doximity has a net margin of 25.48% compared to Heartflow's net margin of -55.82%. Doximity's return on equity of 18.06% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Heartflow	-55.82%	-23.52%	-18.66%

87.2% of Doximity shares are held by institutional investors. 31.8% of Doximity shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Doximity beats Heartflow on 11 of the 15 factors compared between the two stocks.

How does Heartflow compare to Schrodinger?

Schrodinger (NASDAQ:SDGR) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

Schrodinger has a net margin of -20.98% compared to Heartflow's net margin of -55.82%. Schrodinger's return on equity of -16.37% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Schrodinger	-20.98%	-16.37%	-8.19%
Heartflow	-55.82%	-23.52%	-18.66%

79.1% of Schrodinger shares are held by institutional investors. 10.1% of Schrodinger shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Schrodinger currently has a consensus price target of $20.50, suggesting a potential downside of 33.22%. Heartflow has a consensus price target of $46.25, suggesting a potential downside of 7.81%. Given Heartflow's stronger consensus rating and higher possible upside, analysts plainly believe Heartflow is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Schrodinger has higher revenue and earnings than Heartflow. Schrodinger is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Schrodinger	$255.87M	8.86	-$103.26M	-$0.74	N/A
Heartflow	$176.03M	24.78	-$116.79M	-$1.83	N/A

In the previous week, Heartflow had 3 more articles in the media than Schrodinger. MarketBeat recorded 18 mentions for Heartflow and 15 mentions for Schrodinger. Schrodinger's average media sentiment score of 0.62 beat Heartflow's score of 0.44 indicating that Schrodinger is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Schrodinger	7 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	6 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Schrodinger beats Heartflow on 9 of the 16 factors compared between the two stocks.

How does Heartflow compare to Certara?

Certara (NASDAQ:CERT) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Certara presently has a consensus price target of $8.28, indicating a potential downside of 6.25%. Heartflow has a consensus price target of $46.25, indicating a potential downside of 7.81%. Given Certara's higher probable upside, research analysts clearly believe Certara is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Heartflow had 17 more articles in the media than Certara. MarketBeat recorded 18 mentions for Heartflow and 1 mentions for Certara. Heartflow's average media sentiment score of 0.44 beat Certara's score of -0.38 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Heartflow	6 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

74.0% of Certara shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Heartflow	-55.82%	-23.52%	-18.66%

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.22	-$1.60M	-$0.45	N/A
Heartflow	$176.03M	24.78	-$116.79M	-$1.83	N/A

Summary

Certara beats Heartflow on 9 of the 15 factors compared between the two stocks.

How does Heartflow compare to GoodRx?

Heartflow (NASDAQ:HTFL) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

GoodRx has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	24.78	-$116.79M	-$1.83	N/A
GoodRx	$796.85M	1.48	$30.44M	$0.04	86.00

63.8% of GoodRx shares are owned by institutional investors. 7.7% of Heartflow shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Heartflow had 18 more articles in the media than GoodRx. MarketBeat recorded 18 mentions for Heartflow and 0 mentions for GoodRx. Heartflow's average media sentiment score of 0.44 beat GoodRx's score of 0.00 indicating that Heartflow is being referred to more favorably in the media.

Company	Overall Sentiment
Heartflow	Neutral
GoodRx	Neutral

GoodRx has a net margin of 2.07% compared to Heartflow's net margin of -55.82%. GoodRx's return on equity of 7.22% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-55.82%	-23.52%	-18.66%
GoodRx	2.07%	7.22%	2.53%

Heartflow presently has a consensus target price of $46.25, indicating a potential downside of 7.81%. GoodRx has a consensus target price of $4.23, indicating a potential upside of 22.89%. Given GoodRx's higher probable upside, analysts plainly believe GoodRx is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

Summary

GoodRx beats Heartflow on 9 of the 16 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.38B	$1.72B	$7.27B	$13.25B
Dividend Yield	N/A	3.89%	2.53%	13.00%
P/E Ratio	-27.42	21.05	274.29	25.86
Price / Sales	24.78	89.17	634.04	91.22
Price / Cash	N/A	31.68	76.31	52.02
Price / Book	14.21	6.22	10.60	6.42
Net Income	-$116.79M	-$18.66M	$3.49B	$360.08M
7 Day Performance	3.87%	1.63%	2.59%	2.79%
1 Month Performance	0.84%	2.00%	-1.80%	-2.48%
1 Year Performance	39.87%	-16.42%	18.64%	7.15%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	1.9091 of 5 stars	$50.17 -0.3%	$46.25 -7.8%	+59.6%	$4.38B	$176.03M	N/A	843	Analyst Forecast Insider Trade
WAY Waystar	4.2751 of 5 stars	$26.51 -0.3%	$35.27 +33.1%	-32.0%	$5.08B	$1.10B	37.87	1,700
DOCS Doximity	4.41 of 5 stars	$26.56 +2.4%	$32.18 +21.2%	N/A	$4.73B	$644.86M	31.24	880	Trending News
SDGR Schrodinger	1.2079 of 5 stars	$30.24 +26.4%	$20.50 -32.2%	+55.7%	$2.23B	$255.87M	N/A	850	Insider Trade High Trading Volume
CERT Certara	1.1134 of 5 stars	$8.58 +5.5%	$8.28 -3.5%	-24.4%	$1.31B	$418.84M	N/A	1,576

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors